SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction

Hidefumi Fukushima1, Akinobu Matsumoto, Hiroyuki Inuzuka

  • 1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Cell Reports
|June 19, 2012
PubMed

Insights

The F-box protein 7 (Fbw7) E3 ligase controls NFkB2/p100 stability via ubiquitination and destruction. This regulation impacts NFkB signaling, cell death sensitivity, and T cell differentiation, suggesting Fbw7

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Immunology

Background:

  • NFkB/Rel proteins are crucial for cellular processes, requiring tight physiological control.
  • NFkB2/p100 acts as a suppressor of NFkB, but its degradation mechanism is unclear.
  • SCF(Fbw7) is a ubiquitin ligase complex implicated in protein degradation.

Purpose of the Study:

  • To elucidate the molecular mechanism regulating NFkB2/p100 degradation.
  • To investigate the role of SCF(Fbw7) in controlling NFkB2/p100 stability.
  • To determine the physiological consequences of Fbw7-mediated regulation of NFkB signaling.

Main Methods:

  • Utilized Fbw7 knockout (Fbw7-/-) cells to study NFkB2/p100 levels.
  • Employed GSK3 inhibition to assess its role in NFkB2 ubiquitination and destruction.
  • Introduced wild-type and mutant Fbw7 to rescue NFkB activity.
  • Depleted Fbw7 in T cells to examine effects on NFkB signaling and differentiation.

Main Results:

  • NFkB2/p100 ubiquitination and destruction are regulated by SCF(Fbw7) in a GSK3-dependent manner.
  • Fbw7 deficiency leads to increased NFkB2/p100, reduced NFkB signaling, and heightened sensitivity to TNFa-induced cell death.
  • Reintroduction of wild-type Fbw7 restores NFkB activity, while mutants do not.
  • T cell-specific Fbw7 depletion reduces NFkB activity and impairs T cell differentiation.

Conclusions:

  • Fbw7 is identified as the physiological E3 ligase governing NFkB2/p100 stability.
  • Fbw7's regulation of NFkB activity may contribute to its tumor-suppressor function.
  • Dysregulation of Fbw7 impacts NFkB signaling and T cell homeostasis.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...